Skip to content
Review

Targeting cytokine-driven neuroinflammation in Alzheimer’s disease: mechanistic insights and pharmacological strategies

Sep 2026 · InflammoPharmacology · Vol 34, pp. 6487 - 6517 · 0 citations · 132 references
Medicine

TL;DR

This review provides a comprehensive overview of cytokine-mediated neuroinflammation in Alzheimer's disease, focusing on the cellular sources of cytokine production within the brain, including microglia, astrocytes, neurons, and endothelial cells.

View source

Similar papers

Review Open access Sep 2026

The Role of Neuroinflammation in Alzheimer's Disease: Molecular Mechanisms and Emerging Therapeutic Approaches

This review examines the molecular and cellular mechanisms through which neuroinflammation contributes to the progression of AD, with particular emphasis on microglial activation, TREM2 and soluble TREM2 (sTREM2) signaling, NLRP3 inflammasome activation, astrocyte–microglia interactions, and blood–brain barrier dysfunc...

Shreyansh Goswami · 0 citations
Review Open access Aug 2026

Microglial dysfunction and NLRP3 inflammasome signaling in Alzheimer’s disease: mechanistic insights into neuroinflammation and neurodegeneration

Alzheimer's disease (AD) is a progressively debilitating neurodegenerative condition characterized by the accumulation of amyloid-β (Aβ), tau pathology, synaptopathy, and neuron loss. Recent studies suggest that Neuroinflammation is a critical part of the disease process rather than an accompanying feature of the menti...

Almas Meheboob Pathan · 0 citations
Review Open access Sep 2026

Interleukins in Alzheimer's Disease: Mechanisms, Biomarkers, and Therapies

Findings support a move from general anti-inflammatory treatment toward stage-based, biomarker-guided immune regulation, which may reduce cytokine damage while maintaining microglial clearance and repair, and support developing immune-regulating treatments for AD.

Ya-Wen Deng · 0 citations
Review Sep 2026

Alzheimer's Disease (AD) Neuroinflammation and Excitotoxicity: Mechanisms and New Treatment Approaches

Key results show that using anti-inflammatory drugs and therapies that support calcium balance can effectively interrupt the pathological cycle between neuroinflammation and excitotoxicity, and Simultaneously targeting multiple interconnected pathogenic pathways is a promising therapeutic strategy for reducing neurodeg...

Mayank Saini, Tanuj Hooda, Anushka Sood et al. · 0 citations
Review Aug 2026

Pyroptosis in Alzheimer's disease: Mechanisms and neuroinflammatory networks.

Overall, pyroptosis provides a novel framework for understanding the interplay between neuroinflammation and neurodegeneration in AD; however, its cell-type-specific roles, stage-dependent effects, and translational potential remain to be fully elucidated.

Xin-Kai Wu, Qiuyan Ye, Ming-Sheng Zi et al. · 0 citations
Review Open access Aug 2026

The NLRP3 Inflammasome and Pro-Inflammatory Cytokines in Alzheimer's Disease: Molecular Mechanisms, Neuroimmune Crosstalk, Biomarkers, and Emerging Therapeutic Perspectives

The molecular mechanisms underlying NLRP3 inflammasome activation in Alzheimer’s disease, its interaction with pro-inflammatory cytokine networks, and the emerging role of inflammasome-related biomarkers in disease characterization are examined.

Hira Shabbir · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.